VIENNA, Austria – 13 June 2025: The decisions adopted by the Commission on Narcotic Drugs (CND) during its 68th regular session from 10 to 14 March 2025 to add N-pyrrolidino protonitazene (protonitazepyne), N-pyrrolidino metonitazene (metonitazepyne), etonitazepipne (N-piperidinyl etonitazene) and N-desethyl isotonitazene (norisotonitazene) to Schedule I of the Single Convention on Narcotic Drugs of 1961, as amended by the 1972 Protocol, was communicated by the Secretary-General on 9 June 2025 to all Members States and thereby entered into force on the date of receipt of the notification.

The UNODC Early Warning Advisory on New Psychoactive Substances recently recorded it’s 30th unique nitazene report, with ten of these nitazenes having been placed under international control since 2021.

The decisions adopted by the CND to add hexahydrocannabinol (HHC) to Schedule II and carisoprodol to Schedule IV of the Convention on Psychotropic Substances of 1971 will come into force on 6 December 2025. 

  For further information please see:

United Nations Office on Drugs and Crime (UNODC), "March 2025 – UNODC: Five NPS and one medicine "scheduled" at the 68th Session of the Commission on Narcotic Drugs", news clip, 12 March 2025.

United Nations Office on Drugs and Crime (UNODC), "February 2025 – UNODC EWA: Increasing availability of nitazenes calls for global response", news clip, 4 February 2025.

United Nations Office on Drugs and Crime (UNODC), "November 2024 - UNODC EWA: New evolution of “semi-synthetic” cannabinoids", news clip, November 2024.

United Nations Office on Drugs and Crime (UNODC), "January 2025 - WHO: World Health Organization recommends five NPS and one medicine for scheduling", news clip, 24 January 2025.